Abstract
Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran. This drug can be used for patients who need emergency surgery or invasive procedures, as well as those with life-threatening or uncontrolled bleeding.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have